Spatial Genomics & Transcriptomics Market Share, Growth and Forecast Report, 2030

NEW YORK - March 6, 2025 - PRLog -- The global spatial genomics and transcriptomics market has experienced significant growth, generating revenue of USD 420.5 million in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 18.2% from 2024 to 2030, with expectations to reach USD 1,348.5 million by 2030.

This surge is primarily driven by the increasing adoption of these technologies in drug discovery, clinical diagnostics, and carrier screening, alongside a rising prevalence of genetic disorders. Continuous technological innovations in next-generation sequencing (NGS) platforms and substantial funding from both government and private sectors for large-scale biotechnology projects further propel market expansion.

Key Insights

Dominance of Spatial Transcriptomics

In 2023, spatial transcriptomics accounted for approximately 70% of the market revenue. Its advantages in single-cell transcriptomic studies and the growing use of in situ sequencing contribute to its leading position. The availability of automated sequencing technologies, such as laser capture microdissection, addresses the increasing demand for nucleic acid sequencing in single cells or biological specimens.

Browse detailed report analysis on "Spatial Genomics & Transcriptomics Market Growth Report, 2030 (https://www.psmarketresearch.com/market-analysis/spatial-...)"

North America's Significant Market Share

Holding approximately 45% of the market in 2023, North America is expected to maintain robust growth. Factors such as substantial research and development activities, a high prevalence of chronic diseases, and the increasing adoption of NGS technology in genomic and diagnostic research contribute to this dominance. The region's strong research funding and advanced healthcare infrastructure also play pivotal roles.

Technological Innovations Enhancing Market Dynamics

The convergence of high-throughput sequencing techniques with established imaging modalities has led to the introduction of new technologies capable of determining the positions of DNA and RNA within cells. These advancements enable the creation of new approaches to disease management, thereby expanding the applications of spatial genomics and transcriptomics. Continuous innovations in NGS platforms and genome disruption techniques, such as CRISPR/Cas9, further bolster the market's growth prospects.

Strategic Collaborations Fueling Market Expansion

Major market competitors are expanding their spatial transcriptomics and genomics footprint through strategic alliances and partnerships. For instance, Dovetail Genomics announced the global availability of its Dovetail HiChIP and Micro-C Kits in February 2020, exemplifying the industry's commitment to advancing spatial genomics and transcriptomics technologies.

The spatial genomics and transcriptomics market is poised for substantial growth, driven by technological advancements, increasing applications in drug discovery and diagnostics, and strategic collaborations among key industry players. As research and development efforts intensify globally, the market is expected to continue its upward trajectory, offering innovative solutions for complex biological challenges.